And it does indeed cause increases in circulating growth hormone and increases in IGF-1
Removal from Category 2 does not guarantee long-term regulatory acceptance, nor does it replace the need for clinical judgment, proper sourcing, and compliance with federal and state guidelines
Cyanocobalamin remains very effective for healthy people supplementing their daily requirement or treating vitamin B12 deficiencies and is globally prescribed to treat vitamin B12 deficiencies
What I would like to see next If BPC-157 truly helps acute soft tissue injury, it should be demonstrable in well-designed human studies with practical endpoints: time to return to sport, functional scores, re-injury rates, adverse events, and standardized imaging where appropriate
Comparative activity of proline-containing dipeptide noopept and inhibitor of dipeptidyl peptidase-4 sitagliptin in a rat model of developing diabetes